Ashraf-Ganjoei T, Behtash N, Shariat M, Mosavi A. Low grade endometrial stromal sarcoma of uterine corpus, a clinico-pathological and survey study in 14 cases. World J Surg Oncol. 2006;4:50.
Ganjoei TA, Behtash N, Shariat M, Mosavi A. Low grade endometrial stromal sarcoma of uterine corpus, a clinicopathological and survey study in 14 cases. World J Surg Oncl. 2006;4:50.
Berek JS, editor. Novaks gynaecology 14th edn. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 1382–4.
Mert G, Aydin C, Cenk MG, Ali B, Seyran Y. A case of malignant low grade endometrial stromal sarcoma and review of the literature. J Turkish Germangynecol Assoc. 2004;5(1):73–5.
Husseiny GE, Bareedy NA, Mourad WA, Mohamed G, Shoukri M, Subhi J. Prognostic factors and treatment modalities in uterine sarcoma. Am J Clin Oncol. 2002;25:256–60. doi:10.1097/00000421-200206000-00010.
NCCN Clinical practice guidelines in oncology. Uterine neoplasms. 2009; 2.
Linder T, Pink D, Kretzschmar A, Mrozek A, Patience PC, Reichardt P. Hormone treatment of endometrial stromal sarcomas: a possible indication for aromatase inhibitors. J Clin Oncol. 2005;23(16S):9057.
Mukhopadhyay P, Sharma PP, Muraleedharan PD, Sarkar S. A case of endometrial stromal sarcoma. J Obstet Gynecol India. 2008;58(1):73–4.
Shafi M, Luesley DM, Jordan JA. Gynecological oncology. New York: Churchil Livingstone; 2001. p. 120–1.
Spano JP, Soria JC, Kambouchner M, Piperno-Neuman S, Morin F, Morere JF, Martin A, Breau JL. Long term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma. Med Oncol. 2003;20:87–93. doi:10.1385/MO:20:1:87.